Literature DB >> 3051006

Divergent disease patterns in granulocyte-macrophage colony-stimulating factor transgenic mice associated with different transgene insertion sites.

D Metcalf1, J G Moore.   

Abstract

A comparison was made of disease development in two lines of transgenic mice in which the granulocyte-macrophage colony-stimulating factor (GM-CSF) transgene was inserted in different chromosomal locations. Female-line mice (X chromosome insertion) had equivalent elevations of serum GM-CSF levels to those in male-line mice (autosomal insertion) but a shorter survival (median survival, 95 versus 145 days) and a significantly higher incidence of large inflammatory foci in skeletal muscle and gut congestion. Male-line transgenic mice had higher levels of cells in the peritoneal cavity and a higher frequency of spleen enlargement with excess erythropoiesis than female-line mice and uniquely developed fibrotic nodules in the abdominal and pleural cavities. The various diseases in GM-CSF transgenic mice are likely to have been induced by GM-CSF-stimulated products of macrophages, and in the two transgenic lines the macrophages exhibit characteristic differences in morphology and possibly functional activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3051006      PMCID: PMC282274          DOI: 10.1073/pnas.85.20.7767

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity.

Authors:  M K Warren; P Ralph
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

2.  Stimulation of macrophage plasminogen activator activity by colony-stimulating factors.

Authors:  J A Hamilton; E R Stanley; A W Burgess; R K Shadduck
Journal:  J Cell Physiol       Date:  1980-06       Impact factor: 6.384

3.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

4.  Interferon induction in marrow-derived macrophages: regulation by L cell conditioned medium.

Authors:  H B Fleit; M Rabinovitch
Journal:  J Cell Physiol       Date:  1981-09       Impact factor: 6.384

5.  Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.

Authors:  S Vadhan-Raj; M Keating; A LeMaistre; W N Hittelman; K McCredie; J M Trujillo; H E Broxmeyer; C Henney; J U Gutterman
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

6.  Hemopoietic responses in mice injected with purified recombinant murine GM-CSF.

Authors:  D Metcalf; C G Begley; D J Williamson; E C Nice; J De Lamarter; J J Mermod; D Thatcher; A Schmidt
Journal:  Exp Hematol       Date:  1987-01       Impact factor: 3.084

7.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome.

Authors:  J E Groopman; R T Mitsuyasu; M J DeLeo; D H Oette; D W Golde
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245

8.  Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF.

Authors:  R E Donahue; E A Wang; D K Stone; R Kamen; G G Wong; P K Sehgal; D G Nathan; S C Clark
Journal:  Nature       Date:  1986 Jun 26-Jul 2       Impact factor: 49.962

9.  A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.

Authors:  G Agnelli; M R Buchanan; F Fernandez; B Boneu; J Van Ryn; J Hirsh; D Collen
Journal:  Circulation       Date:  1985-07       Impact factor: 29.690

10.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

View more
  8 in total

Review 1.  Animal models for the biological effects of continuous high cytokine levels.

Authors:  M Lübbert; D Jonas; F Herrmann
Journal:  Blut       Date:  1990-11

2.  Anti-bacterial activity of peritoneal cells from transgenic mice producing high levels of GM-CSF.

Authors:  H T Tran; D Metcalf; C Cheers
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

Review 3.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

4.  Bovine alpha s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony-stimulating factor in the milk of transgenic mice.

Authors:  M Uusi-Oukari; J M Hyttinen; V P Korhonen; A Västi; L Alhonen; O A Jänne; J Jänne
Journal:  Transgenic Res       Date:  1997-01       Impact factor: 2.788

Review 5.  Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.

Authors:  Palash Bhattacharya; Isadore Budnick; Medha Singh; Muthusamy Thiruppathi; Khaled Alharshawi; Hatem Elshabrawy; Mark J Holterman; Bellur S Prabhakar
Journal:  J Interferon Cytokine Res       Date:  2015-03-24       Impact factor: 2.607

Review 6.  The colony-stimulating factors and cancer.

Authors:  Donald Metcalf
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

7.  Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages.

Authors:  M O De Nichilo; G F Burns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Elevated levels of GM-CSF and IL-1 in the serum, peritoneal and pleural cavities of GM-CSF transgenic mice.

Authors:  A J Gearing; D Metcalf; J G Moore; N A Nicola
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.